Vishal joined Alvogen in July 2017 as Senior Vice President of US R&D. In this capacity, he is responsible for all aspects of Generics and Brand R&D. Vishal has extensive industry experience in NDA, 505(b)(2) and ANDA space, most recently as Chief Scientific Officer and SVP, Global Generics R&D at Impax Labs. Prior to that, he was Chief Scientific Officer and SVP, Generics and Brand R&D at CorePharma. He also served in positions of increasing responsibility at Mallinckrodt, Pfizer, and Ranbaxy.
Vishal holds a PhD in Pharmaceutics from The University of Georgia, Athens, GA, USA; an MBA in Strategy and Finance from Washington University, St. Louis, MO, USA; an MS in Pharmaceutics from IIT, Banaras Hindu University, India, and a BS in Pharmacy from Amravati University, India. Vishal is a certified Six Sigma Black Belt and a former Officer of the American Association of Pharmaceutical Scientists. He served as Adjunct Assistant Professor at Midwestern College of Pharmacy, Chicago, IL and St. Louis College of Pharmacy, St. Louis, MO. Vishal is an inventor/co-inventor of several patents, has published peer-reviewed research articles, and has given numerous invited presentations around the world.